Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Withdrawn Phase 1 / 2 Trials for Linsitinib (DB06075)

IndicationStatusPhase
DBCOND0028768 (Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01465815Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)Treatment